Rankings
▼
Calendar
AMPH Q3 2016 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
AMPH
Amphastar Pharmaceuticals, Inc.
$863M
Q3 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$64M
Gross Profit
$28M
43.0% margin
Operating Income
$6M
9.0% margin
Net Income
$4M
6.1% margin
EPS (Diluted)
$0.08
QoQ Revenue Growth
-5.6%
Cash Flow
Operating Cash Flow
$1M
Free Cash Flow
-$5M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$429M
Total Liabilities
$100M
Stockholders' Equity
$328M
Cash & Equivalents
$67M
Revenue Segments
Active Pharmaceutical Ingredient Segment
$5M
100%
Geographic Segments
U
$63M
100%
← FY 2016
All Quarters
Q4 2016 →
